FBLN5 is highly expressed and closely related to malignant clinicopathological factors, including poor differentiation, lymph node metastasis, and high tumor stage in GC [19], indicating FBLN5 exhibits tumor-promoting effects in GC. Here, FBLN5 is linked to gastric cancer.